Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Nuvo Pharmaceuticals Inc (NRI.TO)

Nuvo Pharmaceuticals Inc (NRI.TO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 10,363
  • Shares Outstanding, K 11,388
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta 1.70
  • Price/Sales N/A
  • Price/Cash Flow 0.55
  • Price/Book 0.56
Trade NRI.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.61
  • Most Recent Earnings -0.25 on N/A
  • Next Earnings Date 02/23/21
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.05
  • Number of Estimates 1
  • High Estimate -0.05
  • Low Estimate -0.05
  • Prior Year 0.30
  • Growth Rate Est. (year over year) -116.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.80 +13.75%
on 12/17/20
0.95 -4.21%
on 12/29/20
+0.10 (+12.35%)
since 11/30/20
3-Month
0.77 +18.18%
on 11/26/20
0.97 -6.19%
on 10/06/20
-0.01 (-1.09%)
since 09/30/20
52-Week
0.43 +111.63%
on 04/09/20
1.20 -24.17%
on 02/18/20
+0.46 (+102.22%)
since 12/30/19

Most Recent Stories

More News
Nuvo: Q3 Earnings Snapshot

MISSISSAUGA, Ontario (AP) _ Nuvo Pharmaceuticals Inc. (MRVFF) on Monday reported a loss of $14.1 million in its third quarter.

NRI.TO : 0.91 (-4.21%)
Nuvo Pharmaceuticals® to Webcast Live at Life Sciences Investor Forum September 17th

- Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on  LifeSciencesInvestorForum.com -

OTCM : 56.8000 (+1.83%)
NRI.TO : 0.91 (-4.21%)
NRIFF : 0.7475 (+0.39%)
Virtual Conference for Life Sciences Companies and Investors Broadcast Live March 26, 2020

Company executives will share corporate vision and answer audience questions at LifeSciencesInvestorForum.com

OTCM : 56.8000 (+1.83%)
NRI.TO : 0.91 (-4.21%)
MBRX : 1.5000 (+2.04%)
LXX.CN : 8.400 (-1.18%)
RDHL : 0.8501 (-3.63%)
NRIFF : 0.7475 (+0.39%)
ORXOY : 2.3000 (unch)
EMMA : 0.4500 (-4.26%)
LXRP : 0.2249 (-10.68%)
BNIGF : 1.1800 (+61.87%)
Nuvo Pharmaceuticals® to Webcast Live at Life Sciences Investor Forum March 26th

Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on LifeSciencesInvestorForum.com

OTCM : 56.8000 (+1.83%)
NRI.TO : 0.91 (-4.21%)
NRIFF : 0.7475 (+0.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 0.92
1st Resistance Point 0.92
Last Price 0.91
1st Support Level 0.91
2nd Support Level 0.90
3rd Support Level N/A

See More

52-Week High 1.20
Fibonacci 61.8% 0.91
Last Price 0.91
Fibonacci 50% 0.82
Fibonacci 38.2% 0.72
52-Week Low 0.43

See More

Business Summary

Nuvo Pharmaceuticals Inc is a Canadian-focused healthcare company with a diversified portfolio of commercial products. The Company targets several therapeutic areas, including pain, allergy and dermatology. Its aims to in-license and acquire growth-oriented, complementary products for Canadian and international...

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar